Infection, Human Immunodeficiency Virus I
2 competing products in clinical development for Infection, Human Immunodeficiency Virus I.
Pipeline by Phase
Phase 32
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| GSK1349572 (dolutegravir) + raltegravir | Shionogi | Phase 3 | Completed | 40 |
| Dolutegravir + Atripla + Abacavir/Lamivudine + Abacavir/Lamivudine Placebo + Dolutegravir placebo + Atripla placebo | Shionogi | Phase 3 | Completed | 40 |